Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha interferon treatment in atopic dermatitis

D Jullien1, J F Nicolas, A Frappaz

  • 1INSERM U.346, Hôpital E. Herriot, Lyon, France.

Acta Dermato-Venereologica
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a shared decision-making tool for systemic treatment in psoriasis.

Annales de dermatologie et de venereologie·2026
Same author

Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAb.

The journal of allergy and clinical immunology. In practice·2025
Same author

Withdrawal of biologic agents before pregnancy is associated with psoriasis flare.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2025
Same author

Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.

Annales de dermatologie et de venereologie·2024
Same author

Promoting clinical research in community-based practice: Threats and opportunities.

Annales de dermatologie et de venereologie·2024

Interferon alpha 2b showed limited effectiveness in treating atopic dermatitis. Short-term, low-to-intermediate doses did not significantly improve skin lesions or reduce IgE levels in patients.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Elevated serum IgE levels are common in atopic dermatitis patients.
  • Interferon therapy is being explored for various dermatological conditions.

Purpose of the Study:

  • To evaluate the efficacy of interferon alpha 2b in treating atopic dermatitis.
  • To assess the impact of interferon alpha 2b on skin lesions and serum IgE levels.

Main Methods:

  • Eight patients with atopic dermatitis were enrolled.
  • Treatment involved low or intermediate doses of interferon alpha 2b (9-15 x 10(6) U/week) for 4-8 weeks.
  • Skin lesion severity and serum IgE levels were monitored.

Related Experiment Videos

Main Results:

  • Four out of eight patients showed moderate improvement in skin lesions at 4 weeks.
  • Three of these four patients lost the beneficial effect by 8 weeks.
  • No reduction in elevated serum IgE levels was observed during interferon therapy.

Conclusions:

  • Intermediate doses of interferon alpha 2b are not effective for short-term atopic dermatitis treatment.
  • Further research may be needed to explore different dosing or treatment durations.
  • Interferon alpha 2b does not appear to modulate IgE levels in this patient group.